Neurotensin/IL-8 pathway orchestrates local inflammatory response and tumor invasion by inducing M2 polarization of Tumor-Associated macrophages and epithelial-mesenchymal transition of hepatocellular carcinoma cells

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108. doi:10.3322/caac.21262. PMID:25651787.
   PubMed Web of Science ®Google Scholar
• Chen S, Dong Z, Yang P, Wang X, Jin G, Yu H, Chen L, Li L, Tang L, Bai S et al. Hepatitis B virus X protein stimulates high mobility group box 1 secretion and enhances hepatocellular carcinoma metastasis. Cancer Lett. 2017;394:22–32. doi:10.1016/j.canlet.2017.02.011. PMID:28216372.
   PubMed Web of Science ®Google Scholar
• Cheng S, Zhang B, Du JY, Jin YH, Lang HY, Zeng LH. Hepatitis B Surface Antigen Promotes the Invasion of Hepatitis B Virus-Related Hepatocellular Carcinoma Cells by Upregulation of Toll-Like Receptor 2. Viral Immunol. 2017;30:232–9. doi:10.1089/vim.2016.0162. PMID:28061318.
   PubMed Web of Science ®Google Scholar
• Hoyer D, Bartfai T. Neuropeptides and neuropeptide receptors: Drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach. Chem Biodivers. 2012;9:2367–87. doi:10.1002/cbdv.201200288. PMID:23161624.
   PubMed Web of Science ®Google Scholar
• Chandrasekharan B, Nezami BG, Srinivasan S. Emerging neuropeptide targets in inflammation: NPY and VIP. Am J Physiol Gastrointest Liver Physiol. 2013;304:G949–57. doi:10.1152/ajpgi.00493.2012. PMID:23538492.
   PubMed Web of Science ®Google Scholar
• Munoz M, Covenas R. Involvement of substance P and the NK-1 receptor in human pathology. Amino Acids 2014;46:1727–50. doi:10.1007/s00726-014-1736-9. PMID:24705689.
   PubMed Web of Science ®Google Scholar
• Moreira de Macedo S, Guimaraes TA, Feltenberger JD, Sousa Santos SH. The role of renin-angiotensin system modulation on treatment and prevention of liver diseases. Peptides 2014;62:189–96. doi:10.1016/j.peptides.2014.10.005. PMID:25453980.
   PubMed Web of Science ®Google Scholar
• Yu J, Ren X, Chen Y, Liu P, Wei X, Li H, Ying G, Chen K, Winkler H, Hao X. Dysfunctional activation of neurotensin/IL-8 pathway in hepatocellular carcinoma is associated with increased inflammatory response in microenvironment, more epithelial mesenchymal transition in cancer and worse prognosis in patients. PLoS One 2013;8:e56069. doi:10.1371/journal.pone.0056069. PMID:23418512.
   PubMed Web of Science ®Google Scholar
• Ye Y, Long X, Zhang L, Chen J, Liu P, Li H, Wei F, Yu W, Ren X, Yu J. NTS/NTR1 co-expression enhances epithelial-to-mesenchymal transition and promotes tumor metastasis by activating the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma. Oncotarget 2016;7:70303–22. doi:10.18632/oncotarget.11854. PMID:27611941.
   PubMedGoogle Scholar
• Carraway R, Leeman SE. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J Biol Chem 1973;248:6854–61. PMID:4745447.
   PubMed Web of Science ®Google Scholar
• Kleczkowska P, Lipkowski AW. Neurotensin and neurotensin receptors: characteristic, structure-activity relationship and pain modulation–a review. Eur J Pharmacol. 2013;716:54–60. doi:10.1016/j.ejphar.2013.03.004. PMID:23500196.
   PubMed Web of Science ®Google Scholar
• Li J, Song J, Zaytseva YY, Liu Y, Rychahou P, Jiang K, Starr ME, Kim JT, Harris JW, Yiannikouris FB et al. An obligatory role for neurotensin in high-fat-diet-induced obesity. Nature 2016;533:411–5. doi:10.1038/nature17662. PMID:27193687.
   PubMed Web of Science ®Google Scholar
• Cross AS, Azzopardi JG, Krausz T, van Noorden S, Polak JM. A morphological and immunocytochemical study of a distinctive variant of ductal carcinoma in-situ of the breast. Histopathology 1985;9:21–37. PMID:2579885.
   PubMed Web of Science ®Google Scholar
• Myers RM, Shearman JW, Kitching MO, Ramos-Montoya A, Neal DE, Ley SV. Cancer, chemistry, and the cell: molecules that interact with the neurotensin receptors. ACS Chem Biol. 2009;4:503–25. doi:10.1021/cb900038e. PMID:19462983.
   PubMed Web of Science ®Google Scholar
• Morgat C, Mishra AK, Varshney R, Allard M, Fernandez P, Hindie E. Targeting neuropeptide receptors for cancer imaging and therapy: perspectives with bombesin, neurotensin, and neuropeptide-Y receptors. J Nucl Med. 2014;55:1650–7. doi:10.2967/jnumed.114.142000. PMID:25189338.
   PubMed Web of Science ®Google Scholar
• Zhao D, Pothoulakis C. Effects of NT on gastrointestinal motility and secretion, and role in intestinal inflammation. Peptides 2006;27:2434–44. doi:10.1016/j.peptides.2005.12.016. PMID:16872719.
   PubMed Web of Science ®Google Scholar
• Matsushima K, Baldwin ET, Mukaida N. Interleukin-8 and MCAF: Novel leukocyte recruitment and activating cytokines. Chem Immunol. 1992;51:236–65. PMID:1567543.
   PubMedGoogle Scholar
• Gabellini C, Trisciuoglio D, Desideri M, Candiloro A, Ragazzoni Y, Orlandi A, Zupi G, Del Bufalo D. Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression. Eur J Cancer 2009;45:2618–27. doi:10.1016/j.ejca.2009.07.007. PMID:19683430.
   PubMed Web of Science ®Google Scholar
• Shahzad MM, Arevalo JM, Armaiz-Pena GN, Lu C, Stone RL, Moreno-Smith M, Nishimura M, Lee JW, Jennings NB, Bottsford-Miller J, et al. Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis. J Biol Chem 2010;285:35462–70. doi:10.1074/jbc.M110.109579. PMID:20826776.
   PubMed Web of Science ®Google Scholar
• Zhou N, Lu F, Liu C, Xu K, Huang J, Yu D, Bi L. IL-8 induces the epithelial-mesenchymal transition of renal cell carcinoma cells through the activation of AKT signaling. Oncol Lett. 2016;12:1915–20. doi:10.3892/ol.2016.4900. PMID:27588140.
   PubMed Web of Science ®Google Scholar
• Wang L, Tang C, Cao H, Li K, Pang X, Zhong L, Dang W, Tang H, Huang Y, Wei L, et al. Activation of IL-8 via PI3K/Akt-dependent pathway is involved in leptin-mediated epithelial-mesenchymal transition in human breast cancer cells. Cancer Biol Ther. 2015;16:1220–30. doi:10.1080/15384047.2015.1056409. PMID:26121010.
   PubMed Web of Science ®Google Scholar
• Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119:1420–8. doi:10.1172/JCI39104. PMID:19487818.
   PubMed Web of Science ®Google Scholar
• Hwang WL, Yang MH, Tsai ML, Lan HY, Su SH, Chang SC, Teng HW, Yang SH, Lan YT, Chiou SH, et al. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Gastroenterology 2011;141:279–91, 91 e1-5. doi:10.1053/j.gastro.2011.04.008. PMID:21640118.
   PubMed Web of Science ®Google Scholar
• Zhu B, Lin N, Zhang M, Zhu Y, Cheng H, Chen S, Ling Y, Pan W, Xu R. Activated hepatic stellate cells promote angiogenesis via interleukin-8 in hepatocellular carcinoma. J Transl Med. 2015;13:365. doi:10.1186/s12967-015-0730-7. PMID:26593962.
   PubMed Web of Science ®Google Scholar
• Li XP, Yang XY, Biskup E, Zhou J, Li HL, Wu YF, Chen ML, Xu F. Co-expression of CXCL8 and HIF-1alpha is associated with metastasis and poor prognosis in hepatocellular carcinoma. Oncotarget 2015;6:22880–9. doi:10.18632/oncotarget.4412. PMID:26078356.
   PubMedGoogle Scholar
• Kim SS, Cho HJ, Won JH, Bae JI, Kang DR, Lee JD, Shin SJ, Lee KM, Yoo BM, Kim JK et al. Interleukin-8 level as a prognostic marker in patients with hepatitis B virus-associated hepatocellular carcinoma treated with transarterial chemoembolization. Cytokine 2015; 76:449–57. doi:10.1016/j.cyto.2015.07.001. PMID:26163999.
   PubMed Web of Science ®Google Scholar
• Zhang Z-M, Lai ECH, Zhang C, Yu H-W, Liu Z, Wan B-J, Liu L-M, Tian Z-H, Deng H, Sun Q-H, et al. The strategies for treating primary hepatocellular carcinoma with portal vein tumor thrombus. International Journal of Surgery 2015;20:8–16. doi:10.1016/j.ijsu.2015.05.009
   PubMed Web of Science ®Google Scholar
• Carraway RE, Hassan S, Dobner PR. Protein kinase C inhibitors alter neurotensin receptor binding and function in prostate cancer PC3 cells. Regul Pept. 2008;147:96–109. doi:10.1016/j.regpep.2008.01.009. PMID:18313772.
   PubMed Web of Science ®Google Scholar
• Zhao D, Keates AC, Kuhnt-Moore S, Moyer MP, Kelly CP, Pothoulakis C. Signal transduction pathways mediating neurotensin-stimulated interleukin-8 expression in human colonocytes. J Biol Chem. 2001;276:44464–71. doi:10.1074/jbc.M104942200. PMID:11574537.
   PubMed Web of Science ®Google Scholar
• Zhao D, Kuhnt-Moore S, Zeng H, Wu JS, Moyer MP, Pothoulakis C. Neurotensin stimulates IL-8 expression in human colonic epithelial cells through Rho GTPase-mediated NF-kappa B pathways. Am J Physiol Cell Physiol. 2003;284:C1397–404. doi:10.1152/ajpcell.00328.2002. PMID:12584113.
   PubMed Web of Science ®Google Scholar
• Tahmasebi Birgani M, Carloni V. Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy. Int J Mol Sci. 2017;18. pii:E405. doi:10.3390/ijms18020405. PMID:28216578.
   PubMed Web of Science ®Google Scholar
• Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: Integrating immunity's roles in cancer suppression and promotion. Science 2011;331:1565–70. doi:10.1126/science.1203486. PMID:21436444.
   PubMed Web of Science ®Google Scholar
• Croci DO, Zacarias Fluck MF, Rico MJ, Matar P, Rabinovich GA, Scharovsky OG. Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment. Cancer Immunol Immunother 2007;56:1687–700. doi:10.1007/s00262-007-0343-y. PMID:17571260.
   PubMed Web of Science ®Google Scholar
• Castven D, Fischer M, Becker D, Heinrich S, Andersen JB, Strand D, Sprinzl MF, Strand S, Czauderna C, Heilmann-Heimbach S, et al. Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomas. Oncotarget 2017;8:48688–48700; doi:10.18632/oncotarget.16231. PMID:28415775.
   PubMedGoogle Scholar
• Warny M, Keates AC, Keates S, Castagliuolo I, Zacks JK, Aboudola S, Qamar A, Pothoulakis C, LaMont JT, Kelly CP. p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis. J Clin Invest. 2000;105:1147–56. doi:10.1172/JCI7545. PMID:10772660.
   PubMed Web of Science ®Google Scholar
• Hsieh YH, Wu TT, Huang CY, Hsieh YS, Hwang JM, Liu JY. p38 mitogen-activated protein kinase pathway is involved in protein kinase Calpha-regulated invasion in human hepatocellular carcinoma cells. Cancer Res 2007;67:4320–7. doi:10.1158/0008-5472.CAN-06-2486. PMID:17483345.
   PubMed Web of Science ®Google Scholar
• Zhao D, Zhan Y, Zeng H, Koon HW, Moyer MP, Pothoulakis C. Neurotensin stimulates interleukin-8 expression through modulation of I kappa B alpha phosphorylation and p65 transcriptional activity: involvement of protein kinase C alpha. Mol Pharmacol. 2005;67:2025–31. doi:10.1124/mol.104.010801. PMID:15755906.
   PubMed Web of Science ®Google Scholar
• Shahzad A, Knapp M, Lang I, Kohler G. Interleukin 8 (IL-8) – a universal biomarker? Int Arch Med. 2010;3:11. doi:10.1186/1755-7682-3-11. PMID:20550702.
   PubMedGoogle Scholar
• Fernando RI, Castillo MD, Litzinger M, Hamilton DH, Palena C. IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells. Cancer Res. 2011;71:5296–306. doi:10.1158/0008-5472.CAN-11-0156. PMID:21653678.
   PubMed Web of Science ®Google Scholar
• Bates RC, DeLeo MJ 3rd, Mercurio AM. The epithelial-mesenchymal transition of colon carcinoma involves expression of IL-8 and CXCR-1-mediated chemotaxis. Exp Cell Res 2004;299:315–24. doi:10.1016/j.yexcr.2004.05.033. PMID:15350531.
   PubMed Web of Science ®Google Scholar
• Araki S, Omori Y, Lyn D, Singh RK, Meinbach DM, Sandman Y, Lokeshwar VB, Lokeshwar BL. Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer. Cancer Res 2007;67:6854–62. doi:10.1158/0008-5472.CAN-07-1162. PMID:17638896.
   PubMed Web of Science ®Google Scholar
• Millar HJ, Nemeth JA, McCabe FL, Pikounis B, Wickstrom E. Circulating human interleukin-8 as an indicator of cancer progression in a nude rat orthotopic human non-small cell lung carcinoma model. Cancer Epidemiol Biomarkers Prev 2008;17:2180–7. doi:10.1158/1055-9965.EPI-07-2915. PMID:18708412.
   PubMed Web of Science ®Google Scholar
• Rofstad EK, Halsor EF. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts. Cancer Res 2000;60:4932–8. PMID:10987309.
   PubMed Web of Science ®Google Scholar
• Huang W, Chen Z, Zhang L, Tian D, Wang D, Fan D, Wu K, Xia L. Interleukin-8 Induces Expression of FOXC1 to Promote Transactivation of CXCR1 and CCL2 in Hepatocellular Carcinoma Cell Lines and Formation of Metastases in Mice. Gastroenterology 2015;149:1053-67 e14. doi:10.1053/j.gastro.2015.05.058. PMID:26065367.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang Y, Wang S, Dong QZ, Shen Z, Wang W, Tao S, Gu C, Liu J, Xie Y et al. Prospero-related homeobox 1 drives angiogenesis of hepatocellular carcinoma through selectively activating interleukin-8 expression. Hepatology 2017;66:1894–909. doi:10.1002/hep.29337. PMID:28646551.
   PubMed Web of Science ®Google Scholar
• Allavena P, Germano G, Marchesi F, Mantovani A. Chemokines in cancer related inflammation. Exp Cell Res 2011;317:664–73. doi:10.1016/j.yexcr.2010.11.013. PMID:21134366.
   PubMed Web of Science ®Google Scholar
• Li L, Xu L, Yan J, Zhen ZJ, Ji Y, Liu CQ, Lau WY, Zheng L, Xu J. CXCR2–CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 2015;34:129. doi:10.1186/s13046-015-0247-1. PMID:26503598.
   PubMed Web of Science ®Google Scholar
• Kuang DM, Zhao Q, Wu Y, Peng C, Wang J, Xu Z, Yin XY, Zheng L. Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. J Hepatol 2011;54:948–55. doi:10.1016/j.jhep.2010.08.041. PMID:21145847.
   PubMed Web of Science ®Google Scholar
• Van Overmeire E, Laoui D, Keirsse J, Van Ginderachter J, Sarukhan A. Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues. Frontiers in immunology 2014;5:127. doi:10.3389/fimmu.2014.00127. PMID:24723924.
   PubMed Web of Science ®Google Scholar
• Karnevi E, Andersson R, Rosendahl AH. Tumour-educated macrophages display a mixed polarisation and enhance pancreatic cancer cell invasion. Immunol Cell Biol 2014;92:543–52. doi:10.1038/icb.2014.22. PMID:24662521.
   PubMed Web of Science ®Google Scholar
• Fujita Y, Okamoto M, Goda H, Tano T, Nakashiro K, Sugita A, Fujita T, Koido S, Homma S, Kawakami Y, et al. Prognostic significance of interleukin-8 and CD163-positive cell-infiltration in tumor tissues in patients with oral squamous cell carcinoma. PLoS One 2014;9:e110378. doi:10.1371/journal.pone.0110378. PMID:25461761.
   PubMed Web of Science ®Google Scholar
• Fang W, Ye L, Shen L, Cai J, Huang F, Wei Q, Fei X, Chen X, Guan H, Wang W, et al. Tumor-associated macrophages promote the metastatic potential of thyroid papillary cancer by releasing CXCL8. Carcinogenesis 2014;35:1780–7. doi:10.1093/carcin/bgu060. PMID:24608042.
   PubMed Web of Science ®Google Scholar
• Manchado E, Weissmueller S, Morris JPt, Chen CC, Wullenkord R, Lujambio A, de Stanchina E, Poirier JT, Gainor JF, Corcoran RB, et al. A combinatorial strategy for treating KRAS-mutant lung cancer. Nature 2016;534:647–51. doi:10.1038/nature18600. PMID:27338794.
   PubMed Web of Science ®Google Scholar
• Hampl V, Martin C, Aigner A, Hoebel S, Singer S, Frank N, Sarikas A, Ebert O, Prywes R, Gudermann T et al. Depletion of the transcriptional coactivators megakaryoblastic leukaemia 1 and 2 abolishes hepatocellular carcinoma xenograft growth by inducing oncogene-induced senescence. EMBO molecular medicine 2013;5:1367–82. doi:10.1002/emmm.201202406. PMID:23853104.
   PubMed Web of Science ®Google Scholar